Chinese Manufacturer Cited for Sanitation, Sterility Issues

Drug Industry Daily
A A
The FDA hit Chinese API manufacturer Jiangsu Yongan Pharmaceuticals with a Form 483 over serious deficiencies relating to poor sanitation, record keeping and training.

To View This Article:

Login

Subscribe To Drug Industry Daily